Watch These Hot Ones: Analogic Corporation (NASDAQ:ALOG), On Assignment (NYSE:ASGN), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Great Basin Scientific (NASDAQ:GBSN)

General Motors Company (NYSE:GM) shares fell -3.58% in last trading session and ended the day at $31.27. GM Gross Margin is 11.70% and its has a return on assets of 2.50%. General Motors Company (NYSE:GM) quarterly performance is -1.93%.

General Motors (NYSE: GM) and its joint ventures delivered a record 3,612,635 vehicles in China in 2015, which was up 5.2 percent from the previous high in 2014. China remained GM’s largest market in terms of retail sales.

Analogic Corporation (NASDAQ:ALOG) ended the last trading day at $78.51. Company weekly volatility is calculated as 2.53% and price to cash ratio as 7.47. Analogic Corporation (NASDAQ:ALOG) showed a weekly performance of -7.90%.

Analogic Corporation (NASDAQ:ALOG), announced that Jim Green, president and CEO, will be speaking at two investor conferences in January. Jim will speak at the CJS Securities 16th Annual “New Ideas for the New Year” Conference in New York City on Wednesday, January 13, 2016. This conference will not be webcast.

On 06 January, On Assignment Inc. (NYSE:ASGN) shares fell -0.49% and was closed at $42.41. ASGN EPS growth in last 5 year was 62.20%. On Assignment Inc. (NYSE:ASGN) year to date (YTD) performance is -5.65%.

Deutsche Bank cut shares of On Assignment, Inc. (NYSE:ASGN) from a buy rating to a hold rating in a research note released on Wednesday morning, The Flyreports.

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares increased 1.53% in last trading session and ended the day at $102.40. VRX Gross Margin is 75.00% and its has a return on assets of 1.50%. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) quarterly performance is -38.31%.

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced that Howard B. Schiller has been appointed interim chief executive officer of Valeant, effective immediately. Mr. Schiller served as Valeant’s chief financial officer from December 2011 through June 2015 and currently serves on Valeant’s Board of Directors. Valeant also announced that Robert Ingram, Lead Independent Director, will serve as interim chairman of the Board of Directors.

Great Basin Scientific, Inc. (NASDAQ:GBSN) caters to the Healthcare space. Its weekly performance is -43.24%. On the last day of trading company shares ended up at $0.66. Great Basin Scientific, Inc. (NASDAQ:GBSN) distance from 50-day simple moving average (SMA50) is -2.78%.

Great Basin Scientific, Inc. (NASDAQ:GBSN), announced it added 46 new customers in the fourth quarter of 2015. As of December 31st, the company had secured 186 U.S. customers, compared to 84 customers reported at the end of December 2014, representing an increase of 121 percent year over year. Further, Great Basin’s Group B Streptococcus (GBS) test—which was commercially launched on June 1, 2015—has now been adopted by or is scheduled to be evaluated by 80 sites, which represents 43 percent of the Company’s customer base.